CH666755A5 - Kontaktlinsenspuelloesung zum nachbehandeln von hydroweichen kontaktlinsen. - Google Patents
Kontaktlinsenspuelloesung zum nachbehandeln von hydroweichen kontaktlinsen. Download PDFInfo
- Publication number
- CH666755A5 CH666755A5 CH209884A CH209884A CH666755A5 CH 666755 A5 CH666755 A5 CH 666755A5 CH 209884 A CH209884 A CH 209884A CH 209884 A CH209884 A CH 209884A CH 666755 A5 CH666755 A5 CH 666755A5
- Authority
- CH
- Switzerland
- Prior art keywords
- contact lens
- rinsing solution
- solution
- soft
- lenses
- Prior art date
Links
- 239000012487 rinsing solution Substances 0.000 title claims description 11
- 239000000243 solution Substances 0.000 claims description 26
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 25
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M potassium chloride Inorganic materials [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 23
- 235000002639 sodium chloride Nutrition 0.000 claims description 19
- 239000000645 desinfectant Substances 0.000 claims description 14
- 239000001103 potassium chloride Substances 0.000 claims description 13
- 235000011164 potassium chloride Nutrition 0.000 claims description 13
- 239000011780 sodium chloride Substances 0.000 claims description 13
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 8
- 235000010755 mineral Nutrition 0.000 claims description 8
- 239000011707 mineral Substances 0.000 claims description 8
- 150000002500 ions Chemical class 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 2
- 239000011833 salt mixture Substances 0.000 claims description 2
- -1 salt potassium chloride Chemical class 0.000 claims 3
- 238000002386 leaching Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 239000012530 fluid Substances 0.000 description 7
- 239000011734 sodium Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000004140 cleaning Methods 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 229910001414 potassium ion Inorganic materials 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 3
- 206010013774 Dry eye Diseases 0.000 description 3
- 208000019025 Hypokalemia Diseases 0.000 description 3
- 210000000795 conjunctiva Anatomy 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 208000007645 potassium deficiency Diseases 0.000 description 3
- 229910001415 sodium ion Inorganic materials 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 210000002200 mouth mucosa Anatomy 0.000 description 2
- 210000002850 nasal mucosa Anatomy 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical class [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 102000005393 Sodium-Potassium-Exchanging ATPase Human genes 0.000 description 1
- 108010006431 Sodium-Potassium-Exchanging ATPase Proteins 0.000 description 1
- 241000885882 Tarzetta cupularis Species 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 230000009056 active transport Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000000607 artificial tear Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000000882 contact lens solution Substances 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 208000027720 dry mucous membrane Diseases 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
- A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Detergent Compositions (AREA)
- Eyeglasses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19833315974 DE3315974A1 (de) | 1983-05-02 | 1983-05-02 | Sterile, osmotische neutrale salzloesung zum schnellen und gruendlichen auslaugen und abschwemmen der schaedlichen desinfektionschemikalien aus dem material der hydroweichen kontaktlinsen unmittelbar vor dem einsetzen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH666755A5 true CH666755A5 (de) | 1988-08-15 |
Family
ID=6197940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH209884A CH666755A5 (de) | 1983-05-02 | 1984-04-30 | Kontaktlinsenspuelloesung zum nachbehandeln von hydroweichen kontaktlinsen. |
Country Status (2)
| Country | Link |
|---|---|
| CH (1) | CH666755A5 (enrdf_load_stackoverflow) |
| DE (1) | DE3315974A1 (enrdf_load_stackoverflow) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3318211A1 (de) * | 1983-05-19 | 1984-11-22 | Bruno 6000 Frankfurt Koller | Kontaktlinsenpflegemittel, welche schnell und zuverlaessig die desinfektionschemikalien an eine auslaugloesung abgeben |
| DE3926003C2 (de) * | 1989-08-05 | 1994-04-28 | Bruno Koller | Aufbewahrungslösung und Pflegeverfahren für weiche Kontaktlinsen |
| DE3936765C2 (de) * | 1989-08-05 | 1998-10-01 | Bruno Koller | Wässriger Kontaktlinsenreiniger, Verfahren zum Pflegen von Kontaktlinsen und Verwendung des Reinigers |
| AU5661894A (en) * | 1993-10-29 | 1995-05-22 | Mats Ersson | Cleaning solution |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3908680A (en) * | 1973-10-12 | 1975-09-30 | Flow Pharma Inc | Methods for cleaning and bleaching plastic articles |
-
1983
- 1983-05-02 DE DE19833315974 patent/DE3315974A1/de active Granted
-
1984
- 1984-04-30 CH CH209884A patent/CH666755A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE3315974A1 (de) | 1984-11-08 |
| DE3315974C2 (enrdf_load_stackoverflow) | 1991-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE68927631T2 (de) | Wässrige Augenlösung und Verfahren zur Konservierung derselben | |
| DE69513902T2 (de) | Augenpräparat zur Verwendung in künstlicher Tränenflüssigkeit | |
| DE2339867C2 (de) | Wäßrige Reinigungs-, Lagerungs- und Befeuchtungslösung für Kontaktlinsen | |
| Kompa et al. | Comparison of emergency eye-wash products in burned porcine eyes | |
| DE60203691T3 (de) | Verwendung von Dexpanthenol in Kontaktlinsenpflegezusammensetzungen | |
| DE69929555T2 (de) | Verwendung einer Flüssigkeit zur Herstellung einer Dialyselösung für die kontinuierliche rezirkulierende Peritonealdialyse | |
| DE69929550T2 (de) | Albumin enthaltende Lösung für die Peritonealdialyse | |
| DE69432188T2 (de) | Synthetisches Viskoseelastisches Material für physiologische Anwendungen wie für Ophtalmologische Anwendungen | |
| DE2810978A1 (de) | Reinigungsmittel, insbesondere in tablettenform fuer weiche kontaktlinsen | |
| DE1300636B (de) | Mittel zum Benetzen von Kontaktlinsen | |
| MX9603435A (es) | Sistema de aplicacion oftalmica liquida de liberacion sostenida. | |
| DE102006060953A1 (de) | Pharmazeutische Zubereitung für die Behandlung entzündlicher Erkrankungen des Urogenitaltraktes | |
| DE69727811T2 (de) | Verwendung einer glukosehaltigen lösung in der peritonealdialyse mit verminderter bildung von zersetzungsprodukten | |
| Grant et al. | Action of Alkalies on the Corneal Stroma roma | |
| DE69912738T2 (de) | Präparat zur chemisch-mechanischen Behandlung von Karies | |
| DE3315974C2 (enrdf_load_stackoverflow) | ||
| Rabinovitch | Factors influencing the absorption of water and chlorides from the intestine | |
| DE2854278A1 (de) | Reinigungsmittel zum entfernen von ablagerungen auf kontaktlinsen | |
| DE69119707T2 (de) | Einstufiges verfahren zur konservierung von kontaktlinsen | |
| Hörmann et al. | Analytische Untersuchungen über Rinderfibrinogen und-fibrin. Absorptionsspektren, Kohlenhydrate, Tryptophan | |
| Hirschfelder | Studies upon the Vascular and Capillary Phenomena and Supposed Axon Reflexes Concerned in the Development of Edema in Mustard Oil Conjunctivitis, Together with the Effects of Vasodilator Drugs, Local Anesthetics and Vital Stains | |
| Giannaccare et al. | A novel osmoprotectant tear substitute for the treatment of dry eye disease | |
| DE902170C (de) | Verfahren zum Entgiften von halogenhaltigen pharmazeutischen Produkten | |
| DE968469C (de) | Verfahren zur Herstellung von Koerperreinigungs- und Koerperpflegemitteln | |
| DE3625867C2 (de) | Verwendung von Tetrachlordecaoxid in der Ophthalmologie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |